These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


158 related items for PubMed ID: 15782199

  • 1. Libraries enriched for alternatively spliced exons reveal splicing patterns in melanocytes and melanomas.
    Watahiki A, Waki K, Hayatsu N, Shiraki T, Kondo S, Nakamura M, Sasaki D, Arakawa T, Kawai J, Harbers M, Hayashizaki Y, Carninci P.
    Nat Methods; 2004 Dec; 1(3):233-9. PubMed ID: 15782199
    [Abstract] [Full Text] [Related]

  • 2. Alternative splicing of IL-24 in melanocytes by deletion of exons 3 and 5.
    Allen M, Pratscher B, Krepler C, Frei K, Schöfer C, Pehamberger H, Müller M, Lucas T.
    Int J Immunogenet; 2005 Dec; 32(6):375-8. PubMed ID: 16313301
    [Abstract] [Full Text] [Related]

  • 3. Changes in alternative splicing of human and mouse genes are accompanied by faster evolution of constitutive exons.
    Cusack BP, Wolfe KH.
    Mol Biol Evol; 2005 Nov; 22(11):2198-208. PubMed ID: 16049198
    [Abstract] [Full Text] [Related]

  • 4. Candidates for tumor-specific alternative splicing.
    Okumura M, Kondo S, Ogata M, Kanemoto S, Murakami T, Yanagida K, Saito A, Imaizumi K.
    Biochem Biophys Res Commun; 2005 Aug 19; 334(1):23-9. PubMed ID: 16018876
    [Abstract] [Full Text] [Related]

  • 5. Unproductive splicing of SR genes associated with highly conserved and ultraconserved DNA elements.
    Lareau LF, Inada M, Green RE, Wengrod JC, Brenner SE.
    Nature; 2007 Apr 19; 446(7138):926-9. PubMed ID: 17361132
    [Abstract] [Full Text] [Related]

  • 6. RASE: recognition of alternatively spliced exons in C.elegans.
    Rätsch G, Sonnenburg S, Schölkopf B.
    Bioinformatics; 2005 Jun 19; 21 Suppl 1():i369-77. PubMed ID: 15961480
    [Abstract] [Full Text] [Related]

  • 7. Molecular mechanisms regulating the tumor-targeting potential of splice-activated gene expression.
    Hayes GM, Dougherty ST, Davis PD, Dougherty GJ.
    Cancer Gene Ther; 2004 Dec 19; 11(12):797-807. PubMed ID: 15359288
    [Abstract] [Full Text] [Related]

  • 8. Intronic UGG repeats coordinate splicing of CD44 alternative exons v8 and v9.
    Galiana-Arnoux D, Del Gatto-Konczak F, Gesnel MC, Breathnach R.
    Biochem Biophys Res Commun; 2005 Oct 21; 336(2):667-73. PubMed ID: 16137657
    [Abstract] [Full Text] [Related]

  • 9. Assessing the application of Ka/Ks ratio test to alternatively spliced exons.
    Xing Y, Lee C.
    Bioinformatics; 2005 Oct 01; 21(19):3701-3. PubMed ID: 16091412
    [Abstract] [Full Text] [Related]

  • 10. Accurate identification of alternatively spliced exons using support vector machine.
    Dror G, Sorek R, Shamir R.
    Bioinformatics; 2005 Apr 01; 21(7):897-901. PubMed ID: 15531599
    [Abstract] [Full Text] [Related]

  • 11. Identification of three mouse mu-opioid receptor (MOR) gene (Oprm1) splice variants containing a newly identified alternatively spliced exon.
    Doyle GA, Rebecca Sheng X, Lin SS, Press DM, Grice DE, Buono RJ, Ferraro TN, Berrettini WH.
    Gene; 2007 Feb 15; 388(1-2):135-47. PubMed ID: 17156941
    [Abstract] [Full Text] [Related]

  • 12. Evidence for the regulation of alternative splicing via complementary DNA sequence repeats.
    Lian Y, Garner HR.
    Bioinformatics; 2005 Apr 15; 21(8):1358-64. PubMed ID: 15673565
    [Abstract] [Full Text] [Related]

  • 13. Analysis of the prostate cancer cell line LNCaP transcriptome using a sequencing-by-synthesis approach.
    Bainbridge MN, Warren RL, Hirst M, Romanuik T, Zeng T, Go A, Delaney A, Griffith M, Hickenbotham M, Magrini V, Mardis ER, Sadar MD, Siddiqui AS, Marra MA, Jones SJ.
    BMC Genomics; 2006 Sep 29; 7():246. PubMed ID: 17010196
    [Abstract] [Full Text] [Related]

  • 14. Alternative promoter usage and alternative splicing contribute to mRNA heterogeneity of mouse monocarboxylate transporter 2.
    Zhang SX, Searcy TR, Wu Y, Gozal D, Wang Y.
    Physiol Genomics; 2007 Dec 19; 32(1):95-104. PubMed ID: 17911380
    [Abstract] [Full Text] [Related]

  • 15. A statistical framework for genome-wide discovery of biomarker splice variations with GeneChip Human Exon 1.0 ST Arrays.
    Yoshida R, Numata K, Imoto S, Nagasaki M, Doi A, Ueno K, Miyano S.
    Genome Inform; 2006 Dec 19; 17(1):88-99. PubMed ID: 17503359
    [Abstract] [Full Text] [Related]

  • 16. Alternative splicing of human and mouse NPFF2 receptor genes: Implications to receptor expression.
    Ankö ML, Ostergård M, Lintunen M, Panula P.
    FEBS Lett; 2006 Dec 22; 580(30):6955-60. PubMed ID: 17157836
    [Abstract] [Full Text] [Related]

  • 17. Estradiol regulates alternative splicing of estrogen receptor-alpha mRNA in differentiated NG108-15 neuronal cells.
    Aizawa S, Yamamuro Y.
    Life Sci; 2008 Mar 26; 82(13-14):692-8. PubMed ID: 18258268
    [Abstract] [Full Text] [Related]

  • 18. Insights into the connection between cancer and alternative splicing.
    Kim E, Goren A, Ast G.
    Trends Genet; 2008 Jan 26; 24(1):7-10. PubMed ID: 18054115
    [Abstract] [Full Text] [Related]

  • 19. Tandem exon duplication tends to propagate rather than to create de novo alternative splicing.
    Peng T, Li Y.
    Biochem Biophys Res Commun; 2009 May 29; 383(2):163-6. PubMed ID: 19351527
    [Abstract] [Full Text] [Related]

  • 20. A potential link between alternative splicing of the NBS1 gene and DNA damage/environmental stress.
    Takai K, Sakamoto S, Sakai T, Yasunaga J, Komatsu K, Matsuoka M.
    Radiat Res; 2008 Jul 29; 170(1):33-40. PubMed ID: 18582154
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.